Tags:BioTechDevelopmentDrugEngineeringGrowthManufacturingPublicResearch
Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com
Location: United States, Massachusetts, Cambridge
Member count: 201-500
Total raised: $30M
Founded date: 2003

Investors 4

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
23.12.2011-$30M-finsmes.co...

Mentions in press and media 19

DateTitleDescriptionCategoryAuthorSource
01.10.2021Why the au...This is the web version of Ter...--fortune.co...
01.10.2021Why the au...This is the web version of Ter...--fortune.co...
30.09.2021Merck to b...Merck & Co. agreed to buy ...--business-s...
18.06.2021ACCELERON ...Reblozyl was generally well to...--marketscre...
29.03.2019bluebird’s...Shares of bluebird on the Nasd...--medcitynew...
20.03.2019Flagship P...“With each year of company ori...--medcitynew...
03.01.2018A bet­ter ...Schol­ar Rock, a biotech based...FinancingBrittany M...endpts.com...
26.03.2015Flagship V...The company’s previous fund wa...--medcitynew...
01.11.2013OrbiMed cl...Looking back 5 to 6 years, hea...--medcitynew...
30.10.2013Which vent...I won’t get into Aratana Thera...--medcitynew...
Show more